002019.SZ
002019.SZ
CNE000001K65
YIFAN PHARM
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 5.132.949.330 5.159.823.228
0.5%
Cost of Revenue 2.726.658.412 2.713.055.053
0.5%
Gross Profit 2.406.290.918 2.446.768.175
1.7%
1.829.046.010 1.842.355.962
0.7%
Operating Income 577.244.908 604.412.213
4.5%
Pretax Income 423.704.237 388.656.952
9.0%
Net Income Common Stockholders 402.021.184 385.967.573
4.2%
-- --
--
-- --
--
ende